Entrada Therapeutics, Inc.
USD7.71
-0.03 (-0.39%)
CEO
Dipal Doshi
IPO Date
2021-10-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.58
Prev. Close
$7.74
Day Low
$7.46
Day High
$7.82
52W Low
$4.93
52W High
$16.45
Market Cap
$0.30B
Volume
0.24M
| 9.8 |
| 31 Dec 2023 | FY | 100.0% | -5.2% | -2.8% | -1.4% | 0.28 | 2.33 | -74.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -44.5% | -37.5% | 0.12 | 9.55 | -4.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -17.1% | -16.7% | 0.00 | 44.46 | -10.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 63.9% | -60.9% | 0.00 | 11.89 | -28.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 30.0% | -25.5% | 0.00 | 9.08 | -5.4 |
| -2.7 |
| 30 Sept 2025 | Q3 | -2276.8% | -2734.4% | -13.0% | -10.7% | 0.15 | 14.08 | -1.4 |
| 30 Jun 2025 | Q2 | 100.0% | -2210.4% | -11.4% | -9.6% | 0.14 | 18.64 | -1.6 |
| 31 Mar 2025 | Q1 | 100.0% | -84.4% | -4.2% | -3.6% | 0.14 | 21.88 | -5.4 |
| 31 Dec 2024 | Q4 | 100.0% | 3.0% | 0.3% | 0.2% | 0.14 | 11.15 | 156.1 |
| 30 Sept 2024 | Q3 | 100.0% | -71.7% | -3.3% | -2.5% | 0.15 | 6.59 | -11.6 |
| 30 Jun 2024 | Q2 | 100.0% | 58.1% | 12.8% | 9.5% | 0.15 | 5.70 | 2.2 |
| 31 Mar 2024 | Q1 | 100.0% | 39.7% | 8.7% | 4.6% | 0.25 | 2.38 | 4.9 |
| 31 Dec 2023 | Q4 | 100.0% | -22.8% | -3.9% | -2.0% | 0.28 | 2.33 | -13.2 |